WC3 reassortant vaccines in children

Archives of Virology, Supplement

Volumn 1996, Issue 12, 1996, Pages 187-198

  Clark, H F ^a,d   Offit, P A ^a   Ellis, R W ^b   Krah, D ^b   Shaw, A R ^b   Eiden, J J ^b   Pichichero, M ^c   Treanor, J J ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL; CATTLE; CHILD; GENETIC REASSORTMENT; HUMAN; IMMUNOLOGY; REVIEW; ROTAVIRUS; VIRUS INFECTION;

ANIMALS; CATTLE; CHILD; HUMANS; REASSORTANT VIRUSES; ROTAVIRUS; ROTAVIRUS INFECTIONS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030339626     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6553-9_20     Document Type: Review

References (25)

1. Acres DS, Radostits OM (1976) The efficacy of a modified live reo-like virus vaccine and an E. coli bacteria for prevention of acute neonatal diarrhea of beef calves. Can Vet J 17: 197-212
2. Bernstein DI, Smith VE, Sander DS, Pax KS, Schiff GM, Ward RL (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162: 1055-1062
3. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. Children. J Amer Med Assoc 273: 1191-1196
4. Bishop RF, Davidson GP, Holmes H, Ruck BJ (1973) Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet 2: 1281-1283
5. Christy C, Madore HP, Treanor JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R (1986) Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis 154: 1045-1047
6. Clark HF, Furukawa T, Bell LM, Offit PA, Perrella PA, Plotkin SA (1986) Immune response of infants and children to low-passage bovine rotavirus (strain WC3). Amer J Dis Children 140: 350-356
7. Clark HF, Borian EF, Bell LM, Modesto K, Gouvea V, Plotkin SA (1988) Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 158: 750-587
8. Clark HF, Borian FE, Modesto K, Plotkin SA (1990a) Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. Vaccine 8: 327-332
9. Clark HF, Borian FE, Plotkin SA (1990b) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 161: 1099-1104
10. Clark HF, Offit PA (1994) Rotavirus vaccines. In: Plotkin SA, Mortimer EA (eds) Vaccines. Saunders, Philadelphia, pp 809-822
11. Clark HF, Welsko D, Offit PA (1992) Infant responses to bovine WC3 reassortants containing human rotavirus VP7, VP4, or VP7 & VP4. ICAAC Anaheim, p 343
12. Clark HF, White CJ, Offit PA, Stinson D, Eiden J, Weaver S, Cho I, Shaw A, Krah D, Ellis R + OHBRV Study Group (1995) Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine. Ped Res 37: 172A
13. Delem A, Lobmann M, Zygraich N (1984) A bovine rotavirus developed as a candidate vaccine for use in humans. J Biol Stand 12: 443-445
14. Estes MK, Graham DY, Petrie BL (1985) Antigenic structure of rotaviruses. In: van Regenmortel MHV, Neurath AR (eds) Immunochemistry of viruses. Elsevier, Amsterdam, pp 389-405
15. Estes MK (1996) Rotaviruses and their replication. In: Fields BN et al. (eds) Virology. Lippincott-Raven Publishers, New York, pp 1625-1655
16. Garbag-Chenon A, Fontaine J-L, Lasfargues G, Clark HF, Guyot J, LeMoing G, Hessel L, Bricout F (1989) Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5-12 month old infants. Res Virol 140: 207-217
17. Georges-Courbot MC, Monges J, Siopathis MR, Roungou JP, Gresenguet G, Bellec L, Bouquety JC, Lanckviet C, Cadoz M, Hessel L, Gouvea G, Clark HF, Georges AJ (1991) Evaluation of the efficacy of a low passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142: 405-411
18. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 149: 694-702
19. Institute of Medicine (1986) The prospects for immunzing against rotavirus. In: New vaccine development. Establishing priorities. Diseases of importance in developing countries, vol II. National Academy Press, Washington, DC, pp 308-318
20. Kobayashi M, Thompson J, Tottlefson SJ, Reed GW, Wright PF (1994) Tetravalent rhesus rotavirus vaccine in young infants. J Infect Dis 170: 1260-1263
21. Mebus CA, Underdahl NR, Rhodes MB, Twiehaus MJ (1969) Calf diarrhea (Scours): reproduced with a virus from a field outbreak. Nebraska Res Bull 233. Nebraska Agricultural Experiment Station, Lincoln, Nebraska
22. Mebus CA, White RG, Stair FL, Rhodes MB, Twiehaus MJ (1972) Neonatal calf diarrhea: results of a field trial using a reo-like virus vaccine. Vet Med Ann Clin 67: 173-174
23. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53: 949-954
24. Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit PA (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatric Infect Dis J 14: 301-397
25. Ward RL, Sander DS, Schiff GM, Bernstein DI (1990) Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 162: 1298-1303